GLP-2TZ
Dual GIP + GLP-1 Weight Management Research
GLP-2TZ represents research focused on two important signals involved in hunger, fullness, blood sugar and how the body manages food and energy.
WHAT IS GLP-2TZ?
The simple idea behind this research is to work with two natural systems at the same time: GIP and GLP-1. Both are hormones your body releases after eating. They help communicate with the brain, digestive system and pancreas about food, fullness and blood sugar.
Researchers became interested in combining these two signals because working with both at the same time may have a greater effect on appetite and weight than focusing on GLP-1 alone.
WHY IS THIS BEING STUDIED?
Appetite & Hunger
Being studied for how it can reduce hunger and help people feel satisfied with less food.
Weight Management
Research has shown significant changes in body weight when both GIP and GLP-1 systems are targeted together.
Blood Sugar
Both systems play a role in how the body responds to food and manages blood sugar.
Food & Energy
Researchers are studying how these signals affect eating, calorie intake and the way the body manages energy.
WHAT HAS THE RESEARCH SHOWN?
One of the best-known examples of dual GIP + GLP-1 research is tirzepatide.
In the large SURMOUNT-1 clinical trial, 2,539 adults with overweight or obesity who did not have diabetes were studied for 72 weeks.
​
Average weight loss was approximately:
15.0%
With the 5 mg tirzepatide group
19.5%
With the 10 mg group
20.9%
With the 15 mg group
3.1%
With placebo
15.0%
19.5%
20.9%
With the 5 mg tirzepatide group
With the 10 mg group
With the 15 mg group
These results are from the published SURMOUNT-1 clinical trial of tirzepatide. They describe that specific drug and clinical study and are not a promise or expected result from an OSG BioLabs research product.
Source: Jastreboff et al., New England Journal of Medicine, 2022 — SURMOUNT-1 Trial
WHY HAS THIS RESEARCH RECEIVED SO MUCH ATTENTION?
The major interest comes from combining two signals instead of one. GLP-1 helps with hunger, fullness and blood sugar, while GIP adds another way of responding to food and energy. Research with tirzepatide showed that using both together could produce substantial changes in appetite and body weight.
GLP-2TZ IN SIMPLE TERMS
The simple version:
Think of GLP-1 research as working with one major appetite and blood-sugar signal. This type of research looks at working with two signals together — GIP and GLP-1 — which is why researchers became so interested in its potential for weight management.
RELATED RESEARCH
GLP-1SG
GLP-3RT
For research use only. Not for human consumption.